Showing results (11-20 of 165) with videos related to

Sort By:
Pageof 17
Seminars in Hematology|April 28, 2021
Management of ALCL and other CD30+ peripheral T-cell lymphomas with a focus on Brentuximab vedotinImran Nizamuddin, Carlos Galvez, Barbara Pro
Current Hematology Reports|July 13, 2005
The lymphomas: molecular pathways and novel therapeutic targetsAmanda Wedgwood, Barbara Pro, Anas Younes
Blood|August 7, 2020
Hepatosplenic T-cell lymphoma: a rare but challenging entityBarbara Pro, Pamela Allen, Amir Behdad
Frontiers in Oncology|June 12, 2013
Peripheral T-cell lymphomas: a review of current approaches and hopes for the futureAlan P Skarbnik, Meher Burki, Barbara Pro
Cancers|April 3, 2019
Novel Therapies and Approaches to Relapsed/Refractory HL Beyond ChemotherapyAlain Antoine Mina, Chetan Vakkalagadda, Barbara Pro
Clinical Advances in Hematology & Oncology : H&O|February 25, 2012
Current treatment of peripheral T-cell lymphomaSteven M Horwitz, Bertrand Coiffier, Eric D Hsi, et al.
Ophthalmic Plastic and Reconstructive Surgery|July 24, 2012
Second-line 90Yttrium-ibritumomab tiuxetan (Zevalin) in a patient with conjunctival mucosa-associated lymphoid tissue lymphoma refractory to rituximabPatrick Oellers, Aaron Savar, Felipe Samaniego, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|December 12, 2007
Prevalence and nature of systemic involvement and stage at initial examination in patients with orbital and ocular adnexal lymphomaElham Hatef, Dianna Roberts, Peter McLaughlin, et al.
Cancer|July 27, 2004
Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patientsBouthaina S Dabaja, Dima Suki, Barbara Pro, et al.
Pageof 17